Search Results 911-920 of 16376 for monoclonal antibody

  1. Ocular manifestations in post-transplant lymphoproliferative disorder: A case report - Mayo Clinic

    The anterior segment disease was treated successfully using a combination of intraocular and systemic injections of humanized anti-CD20 antibody (rituximab).

  2. Emerging treatments for multiple sclerosis - Mayo Clinic

    Ublituximab-xiiy is given in a vein and stops certain immune system cells from making antibodies that may damage the brain and spinal cord in MS. Ofatumumab ...

  3. Immune globulin (intramuscular route, intravenous route, subcutaneous route) - Mayo Clinic

    Immune globulin contains antibodies that make your immune system stronger. It is used for patients who have primary humoral immunodeficiency (PI) ...

  4. Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation - Mayo Clinic

    ... monoclonal antibodies) prior to the index hospital admission. Previous administration of S aureus vaccine or S aureus/Candida vaccine. Antibiotic therapy ...

  5. Myelodysplastic Syndromes Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as nivolumab, may interfere with the ability of cancer cells to grow and spread. Midostaurin may stop the growth of cancer cells ...

  6. Chemotherapy and hair loss: What to expect during treatment - Mayo Clinic

    Monoclonal antibody drugs · Mort Crim and Cancer · Mouth cancer · What is mouth cancer? A Mayo Clinic expert explains · Mouth cancer FAQs · Mouth sores caused ...

  7. Radiation Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as durvalumab and tremelimumab, may interfere with the ability of tumor cells to grow and spread. Radiation therapy uses high ...

  8. Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization - Mayo Clinic

    About this study. The purpose of this trial is to determine the safety and efficacy of eculizumab in the prevention of antibody mediated rejection (AMR) in ...

  9. Discovery's Edge: Cell research on amyloidosis - Mayo Clinic News Network

    Antibodies are made up of two parts: “light chain” proteins in the two arms of the Y, and “heavy chain” proteins for the base of the Y. Antibody Protein ...

  10. A Phase 1/​2 Study of STP938 for Adult Subjects With Relapsed/​Refractory B-Cell and T-Cell Lymphomas - Mayo Clinic

    study drug. - Systemic cancer treatments, monoclonal antibody-directed therapies, other investigational agents within 4 weeks before enrollment, or <5 half ...